We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice on preventing drug misuse among vulnerable groups of people, with a focus on understanding factors that contribute to vulnerability.
An assessment of the impact of rescheduling CBPMs to Schedule 2 under the Misuse of Drugs Regulations 2001 (MDR) and recommendations to mitigate the issues identified.
This report provides an updated harms assessment of gamma-hydroxybutyric acid (GHB) and related substances.
This report examines the evidence of prevalence and harms in the UK of several novel benzodiazepines and provides advice to the government.
The Advisory Council on the Misuse of Drugs (ACMD) summarise their contribution to the impact review of the Psychoactive Substances Act 2016
ACMD report providing advice to the government on the factors that make the homeless population vulnerable to substance misuse harms and how these can reduced.
Report from the ACMD providing advice to the government on the changing age profile of people accessing drug treatment and the challenges faced by this cohort in the UK.
Report from the Advisory Council on the Misuse of Drugs (ACMD) on how to reduce drug-related harms that occur when people move between custody and the community.
Independent report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the risk factors to substance use-related problems and harms.
This report by the Advisory Council on the Misuse of Drugs investigates the increase of drug-related deaths in the UK.
ACMD advice on tramadol, February 2013
In October 2010 the minister responsible for drugs asked the ACMD to review khat by considering the available evidence and to advise the government…
The ACMD Recovery Committee’s first report on factors contributing to recovery from drug or alcohol dependence.
In July 2009 the Advisory Council on the Misuse of Drugs (ACMD) provided advice on harmful synthetic compounds.
This report is concerned with advice on the issue of novel psychoactive substances (NPS), sometimes known as ‘legal highs’.
Report of the findings of the ACMD's inquiry on children of problem drug users in the UK.
This is the report of the review of the Advisory Council on the Misuse of Drugs undertaken by Sir David Omand in December 2010.
Released in November 2010, this report by the Advisory Council on the Misuse of Drugs considers the use of foil, as an intervention, to reduce…
This ACMD report, released on 21 September 2010, considers the issue of anabolic steroid misuse. Also available are the annexes to the report…
This report is a consideration of naphyrone (also known as NRG-1, Energy1, or O-2482; or naphthylpyrovalerone), a naphthyl analogue of pyrovalerone…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).